Provexis PLC
10 April 2007
10 April 2007
PROVEXIS PLC
('PROVEXIS' OR 'THE COMPANY')
Result of Meeting
Provexis plc, the nutraceutical company that develops scientifically-proven
functional and medical foods, announces that further to its announcement of 16
March 2007, all of the resolutions proposed at the Extraordinary General Meeting
held earlier today were duly passed.
It is expected that the 143,316,664 new Ordinary Shares of 1p each in the
Company placed at 1.5p per share with institutional and other investors, and
certain of the Company's Directors, will be admitted to AIM on Thursday 12 April
2007. Following Admission, the Company will have in issue 394,355,136 Ordinary
Shares of 1p each.
Certain terms used in this announcement are defined and have the same meaning as
in the Company's announcement of 16 March 2007.
ENQUIRIES
Provexis plc Tel. 020 8392 6634
Stephen Moon, CEO
Arbuthnot Tel. 020 7012 2000
Tom Griffiths
Alasdair Younie
END
This information is provided by RNS
The company news service from the London Stock Exchange